scholarly article | Q13442814 |
P50 | author | Michael B. Wheeler | Q40030429 |
P2093 | author name string | J Li | |
H Wang | |||
Z Lan | |||
R Wang | |||
M Woods | |||
P2860 | cites work | Establishment of duodenojejunal bypass surgery in mice: a model designed for diabetic research | Q46744298 |
First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve | Q46803732 | ||
Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters | Q47356520 | ||
Laparoscopic duodenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI<30 kg/m2 (LBMI). | Q51437697 | ||
c-Kit in early onset of diabetes: a morphological and functional analysis of pancreatic beta-cells in c-KitW-v mutant mice. | Q51466529 | ||
The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats. | Q51468040 | ||
Cellular expression and specific intragranular localization of chromogranin A, chromogranin B, and synaptophysin during ontogeny of pancreatic islet cells: an ultrastructural study. | Q52103683 | ||
Importance of the duodenal passage and pouch volume after total gastrectomy and reconstruction with the Ulm pouch: prospective randomized clinical study. | Q53633402 | ||
Distribution of pancreatic polypeptide and peptide YY | Q28217249 | ||
Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases | Q28294992 | ||
Insulin-promoter-factor 1 is required for pancreas development in mice | Q29619695 | ||
Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. | Q33225025 | ||
Pdx1 inactivation restricted to the intestinal epithelium in mice alters duodenal gene expression in enterocytes and enteroendocrine cells | Q33771760 | ||
Functional and chemical anatomy of the afferent vagal system | Q33934014 | ||
The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes | Q34576196 | ||
Peptide YY(1-36) and peptide YY(3-36): Part II. Changes after gastrointestinal surgery and bariatric surgery | Q36498462 | ||
Bariatric surgery: effects on glucose homeostasis | Q36508543 | ||
Postprandial diabetic glucose tolerance is normalized by gastric bypass feeding as opposed to gastric feeding and is associated with exaggerated GLP-1 secretion: a case report | Q41832470 | ||
Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity | Q42634370 | ||
Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease | Q44699316 | ||
Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty | Q44969260 | ||
Metabolic and neuroendocrine consequences of a duodenal-jejunal bypass in rats on a choice diet | Q46074557 | ||
A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control | Q46585058 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 686-696 | |
P577 | publication date | 2011-03-04 | |
P1433 | published in | British Journal of Surgery | Q4970212 |
P1476 | title | Antidiabetic effects of duodenojejunal bypass in an experimental model of diabetes induced by a high-fat diet | |
P478 | volume | 98 |
Q37717414 | Absence of Role of Dietary Protein Sensing in the Metabolic Benefits of Duodenal-Jejunal Bypass in the Mouse |
Q61433479 | Duodenal-Jejunal Bypass Restores Insulin Action and Βeta-Cell Function in Hypothalamic-Obese Rats |
Q33653361 | Duodenal-jejunal bypass normalizes pancreatic islet proliferation rate and function but not hepatic steatosis in hypothalamic obese rats. |
Q61433514 | Duodenal–Jejunal Bypass Surgery Enhances Glucose Tolerance and Beta-Cell Function in Western Diet Obese Rats |
Q38457192 | High-fat diet ingestion correlates with neuropathy in the duodenum myenteric plexus of obese mice with symptoms of type 2 diabetes |
Q39233208 | Intestinal adaptation and Reg gene expression induced by antidiabetic duodenal-jejunal bypass surgery in Zucker fatty rats |
Q92524569 | Metabolic benefits of gastric bypass surgery in the mouse: The role of fecal losses |
Q50782366 | Phenotype of entero-endocrine L cells becomes restricted during development. |
Q44850761 | Reduction of intestinal electrogenic glucose absorption after duodenojejunal bypass in a mouse model. |
Q83971678 | Roux-en-Y gastric bypass in mice--surgical technique and characterisation |
Q47159019 | Three-year result of efficacy for type 2 diabetes mellitus control between laparoscopic duodenojejunal bypass compared with laparoscopic Roux-en-Y gastric bypass |
Search more.